国际眼科杂志
國際眼科雜誌
국제안과잡지
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY
2014年
2期
243-245
,共3页
青光眼引流植入物%青光眼%新生血管性%治疗效果
青光眼引流植入物%青光眼%新生血管性%治療效果
청광안인류식입물%청광안%신생혈관성%치료효과
glaucoma drainage implants%glaucoma%neovascular%treatment outcome
目的：评价Ahmed青光眼引流阀治疗新生血管性青光眼的临床效果。<br> 方法：回顾性病例研究。收集2011-01/2012-12住院行Ahmed青光眼引流阀植入术治疗的28例28眼新生血管性青光眼患者临床资料，进行回顾性分析。患者随访时间为术后1d；1wk；1，3，6mo及之后的每6mo随访1次。随访内容主要包括患者术后眼压、最佳矫正视力、应用抗青光眼药物种类数及并发症等。术后不同时间点的眼压比较采用重复测量资料的方差分析，手术前后应用抗青光眼药物种类数比较采用秩和检验，术前与末次随访视力比较采用等级资料秩和检验。<br> 结果：不同时间点的眼压比较差异有统计学意义（ F＝11．23， P＜0．05）。术前平均应用抗青光眼药物4．12±0．23种，术后平均应用抗青光眼药物0．56±0．11种，手术前后比较差异有统计学意义（Z＝9．224，P＜0．05）。术前与末次复查视力比较，差异无统计学意义（ Z＝-1．922， P＞0．05）。Ahmed引流阀植入术完全成功率71％，条件成功率86％。术后并发症主要包括引流盘周围包裹性囊状泡、浅前房、低眼压对症处理后眼压均可控制。<br> 结论：Ahmed青光眼引流阀植入术是新生血管性青光眼的安全、有效治疗方式之一。
目的：評價Ahmed青光眼引流閥治療新生血管性青光眼的臨床效果。<br> 方法：迴顧性病例研究。收集2011-01/2012-12住院行Ahmed青光眼引流閥植入術治療的28例28眼新生血管性青光眼患者臨床資料，進行迴顧性分析。患者隨訪時間為術後1d；1wk；1，3，6mo及之後的每6mo隨訪1次。隨訪內容主要包括患者術後眼壓、最佳矯正視力、應用抗青光眼藥物種類數及併髮癥等。術後不同時間點的眼壓比較採用重複測量資料的方差分析，手術前後應用抗青光眼藥物種類數比較採用秩和檢驗，術前與末次隨訪視力比較採用等級資料秩和檢驗。<br> 結果：不同時間點的眼壓比較差異有統計學意義（ F＝11．23， P＜0．05）。術前平均應用抗青光眼藥物4．12±0．23種，術後平均應用抗青光眼藥物0．56±0．11種，手術前後比較差異有統計學意義（Z＝9．224，P＜0．05）。術前與末次複查視力比較，差異無統計學意義（ Z＝-1．922， P＞0．05）。Ahmed引流閥植入術完全成功率71％，條件成功率86％。術後併髮癥主要包括引流盤週圍包裹性囊狀泡、淺前房、低眼壓對癥處理後眼壓均可控製。<br> 結論：Ahmed青光眼引流閥植入術是新生血管性青光眼的安全、有效治療方式之一。
목적：평개Ahmed청광안인류벌치료신생혈관성청광안적림상효과。<br> 방법：회고성병례연구。수집2011-01/2012-12주원행Ahmed청광안인류벌식입술치료적28례28안신생혈관성청광안환자림상자료，진행회고성분석。환자수방시간위술후1d；1wk；1，3，6mo급지후적매6mo수방1차。수방내용주요포괄환자술후안압、최가교정시력、응용항청광안약물충류수급병발증등。술후불동시간점적안압비교채용중복측량자료적방차분석，수술전후응용항청광안약물충류수비교채용질화검험，술전여말차수방시력비교채용등급자료질화검험。<br> 결과：불동시간점적안압비교차이유통계학의의（ F＝11．23， P＜0．05）。술전평균응용항청광안약물4．12±0．23충，술후평균응용항청광안약물0．56±0．11충，수술전후비교차이유통계학의의（Z＝9．224，P＜0．05）。술전여말차복사시력비교，차이무통계학의의（ Z＝-1．922， P＞0．05）。Ahmed인류벌식입술완전성공솔71％，조건성공솔86％。술후병발증주요포괄인류반주위포과성낭상포、천전방、저안압대증처리후안압균가공제。<br> 결론：Ahmed청광안인류벌식입술시신생혈관성청광안적안전、유효치료방식지일。
AIM:To evaluate the efficacy of Ahmed glaucoma valve implantation in neovascular glaucoma ( NVG) . <br> METHODS: This retrospective study collected a total of 28 eyes of 28 neovascular glaucoma patients who underwent Ahmed glaucoma valve implantation in our hospital from January 2011 to December 2012.Change of intraocular pressure, the best corrected visual acuity, numbers of anti-glaucoma medication and postoperative complications were followed up at 1d, 1wk, 1, 3, 6mo, and every 6 months after surgery.Data were analyzed by repeated measures analysis of variance for comparison of intraocular pressure between different time points, rank sum test for paired nonparametric numbers of medication, and rank sum test for visual acuity between pre-operation and the last following-up. <br> RESULTS: Compared with the pre -operation, the intraocular pressure was significant decreased after surgery at all time points ( F =11.23, P<0.05 ).The numbers of anti-glaucoma medication were significant reduced from 4.12±0.23 of pre-operation to 0.56±0.11 of postoperative (Z=9.224, P<0.05).The visual acuity was not significant difference between pre-operation and the last following-up ( Z=-1.922, P>0.05 ).At the last following-up, the complete success rate was 71%, and qualified success rate was 86%. The postoperative complications including encapsulated cystic blebs around the plate, shallow anterior chamber and low intraocular pressure were controlled with additional treatment. <br> CONCLUSION: Ahmed glaucoma valve implantation is safe and effective in the management of neovascular glaucoma.
